News

New regulations on the registration and testing of chemicals could have some problematic knock-on effects on European R&D – but they could also bring some lucrative work the way of contract research organisations.

With licensing and collaboration now the lifeblood of the drug industry, the annual BIO-Europe get-together was focused on partnering. Nuala Moran was there.

Better, brighter, faster – that's where photonic lasers are trying to take us. A lay guide to the technology.

Some strange new ways of raising money are starting to emerge - but would-be borrowers and lenders are still making sense of them.

On the glut of patenting, BASF's rising research budget, football fever in the Commons, and other insights into R&D management

The pace of forming academic spin-out companies picked up in the US in 2004 after a two-year slump, according to a survey released today.

"Basic research may seem very expensive. I am a well-paid scientist. My hourly wage is equal to that of a plumber..." Albert Szent-Györgyi, Nobel-winning chemist

When Google hired Kai-fu Lee from Microsoft to set up the internet company's new R&D centre in Beijing in July, it set off a legal battle that highlights how much is at stake in the rush to cash in on the country's booming economy and vast scientific labour force.